GlassScriptPhysician profile
Noemi Kim
NPI 1477186583
$1,470.90
in general payments reported to CMS, 2019-2025
24 companies · $34.49 in 2025
The $34.49 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,062 · 2022: $284 · 2024: $90.74 · 2025: $34.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $507.25 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $167.79 | 2021-2022 | |
| Amgen INC. | $138.03 | 2021 | |
| Janssen Scientific Affairs, LLC | $124.70 | 2021 | |
| Alexion Pharmaceuticals, INC. | $65.55 | 2021-2022 | |
| Incyte Corporation | $63.51 | 2021 | |
| Seagen INC. | $44.43 | 2021 | |
| Glaxosmithkline, LLC. | $43.93 | 2021 | |
| Janssen Biotech, INC. | $39.78 | 2021 | |
| Lilly USA, LLC | $27.48 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.90 | 2021 | |
| Celgene Corporation | $23.87 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.35 | 2021 | |
| Amag Pharmaceuticals, INC. | $23.15 | 2021 | |
| Dova Pharmaceuticals | $22.61 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.12 | 2021 | |
| Astellas Pharma US INC | $16.11 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.80 | 2021 | |
| Ferring Pharmaceuticals INC. | $15.45 | 2021 | |
| Acrotech Biopharma INC. | $14.73 | 2021 | |
| Eusa Pharma (US) LLC | $14.44 | 2021 | |
| Pfizer INC. | $13.66 | 2021 | |
| Global Blood Therapeutics, INC. | $13.27 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $11.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noemi Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.